GHGebretekle Gebremichael Hailesilase

Gebretekle Gebremichael Hailesilase

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gebretekle Gebremichael Hailesilase has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction to: In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia

    by Brhane Gebrehiwot Welegebrial, Zenawi Gezae, Samrawit Kidanemariam Gebrekidan, Gebru Gebremeskel Gebrerufael, Haylay Araya Gebregzabiher, Abrahaley Mulu Kidane, Gebretekle Gebremichael Hailesilase

  • Open Access

    Appropriateness of oral anticoagulant therapy and associated factors among hospitalized atrial fibrillation patients with the CHA2DS2-VASc score of 1 (beyond sex)

    by Gebretekle Gebremichael Hailesilase, Gebru Hagos Atsbha, Haylay Araya Gebrezgabiher, Abrahaley Mulu Kidane

  • Open Access

    In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia

    by Brhane Gebrehiwot Welegebrial, Zenawi Gezae, Samrawit Kidanemariam Gebrekidan, Gebru Gebremeskel Gebrerufael, Haylay Araya Gebregzabiher, Abrahaley Mulu Kidane, Gebretekle Gebremichael Hailesilase

    Background: Administration of poor-quality medications can result in various effects that jeopardize the drugs’ safety and effectiveness. Due to a lack of adequate post-market surveillance studies, making decisions regarding the quality of medicines, including metformin hydrochloride tablets, available in Mekelle City is challenging. Thus, the aim of the study was to evaluate the quality of different brands of metformin hydrochloride tablets sold in Mekelle City, Tigray Regional State, Ethiopia. Methods: A total of eight brands of 500 mg metformin hydrochloride tablets were collected from drug retail outlets in Mekelle City. In vitro quality control tests were conducted based on the WHO visual inspection tool and United States Pharmacopeia (USP) specifications. These included visual inspection, weight variation, thickness, hardness, friability, disintegration time, dissolution, and an assay of active ingredient. One-way ANOVA was used to compare all parameters of quality control. A difference was deemed statistically significant when P < 0.05. One-way ANOVA, model-independent approaches, and model-dependent approaches were used to compare the dissolution profiles and to determine the nature of active pharmaceutical ingredient release. Results: This study showed that all metformin hydrochloride brands marketed in Mekelle City complied with the WHO visual inspection and USP specifications for visual inspection, weight variation, friability, disintegration time, and assay of the active ingredient. Of the samples tested, brand E and brand F exhibited the highest and lowest hardness values, respectively, at 313.88 N and 10.06 N. Moreover, all eight brands evaluated released more than 80% of their drug contents within 30 min as outlined in the USP. However, the difference factor (f 1 ) and similarity factor (f 2 ) have indicated that only brands A, E, and H were similar (can be used interchangeably) with the comparator product. Weibull release model suits the drug release data, which had the highest correlation coefficient. Conclusions: All brands met pharmacopoeial specifications, but significant variations in hardness and dissolution profiles were observed, with only three brands showing profile similarity to the comparator. Hence, the finding serves as an alert to examine the dossier evaluations and legal approval processes of the Ethiopian Food and Drug Authority.


  • Open Access

    Antibiotic prescribing patterns using World Health Organization/International Network for Rational Use of Drug prescribing indicators and its determinants in Eastern Tigrai, Ethiopia: A need for antimicrobial stewardship programs

    by Gebretekle Gebremichael Hailesilase, Haylay Araya Gebrezgabiher, Brhane Gebrehiwot Welegebrial, Abrahaley Mulu Kidane

    Objectives: Antibiotics have diminished mortality rates associated with bacterial infections. However, their misuse worsens antimicrobial resistance. This study aimed to evaluate antibiotic prescribing patterns using World Health Organization/International Network for Rational Use of Drug prescribing indicators and its determinants at public hospitals in Eastern Tigrai, Ethiopia. Methods: A multicenter cross-sectional study was done among encounters prescribed from 1 December 2023 to 30 November 2024 at Doctor Tsegay, Freweyni, and Fre-Semaetat Primary Hospitals. A total of 1800 encounters were selected using systematic random sampling. Data collected from 01 December 2024 to 31 January 2025 were analyzed using SPSS version 21. Binary logistic regression was done to identify determinants of antibiotic prescribing setting statistical significance at p < 0.05. A model fitness test was performed using the Hosmer–Lemeshow goodness-of-fit. Results: Antibiotics were prescribed in 65.7% of encounters (1183/1800), totaling 1465 antibiotics. The mean prescribing indicators were 1.24 (Standard deviation 0.48) antibiotics per encounter, and 26.4% of encounters included an injection. Nearly all antibiotics were prescribed from the essential medicine list (99.6%) and by generic name (97.5%). Overall, 67.0% of antibiotics were classified under the “Access” group and 33.0% under the “Watch” group, with none from the “Reserve” group. Factors significantly associated with antibiotic prescribing included being under 18 years of age (adjusted odds ratio = 2.6; 95% confidence interval: 1.54–4.2), receiving ⩾3 drugs (adjusted odds ratio = 7.8; 95% confidence interval: 5.4–11.4), having ⩾2 diseases (adjusted odds ratio = 2.1; 95% confidence interval: 1.27–3.4), and presenting diseases of the genitourinary system (adjusted odds ratio = 9.4; 95% confidence interval: 3.9–22.8). Conclusion: Antibiotic prescribing practices were not aligned with World Health Organization standards, indicating substantial overuse. Such patterns may contribute to the worsening of antimicrobial resistance. Strengthening adherence to World Health Organization and national treatment guidelines is essential to promote rational use of antibiotics in these hospitals.


  • Open Access

    Determinants of HIV infection among infants born to HIV positive women receiving option B + prevention of mother to child transmission of HIV in Tigray, north Ethiopia: a case control study

    by Haftay Gebremedhin, Fre Gebremeskel, Gebremedhin Gebreegziabiher, Abadi Hailay Atsbaha, Gebretekle Gebremichael Hailesilase

    Background: The option B+ prevention of mother to child transmission of human immunodeficiency virus is the lifelong provision of antiretroviral therapy for all human immunodeficiency virus positive pregnant and breastfeeding women regardless of immune status. In Ethiopia, the overall mother-to-child transmission rate of human immunodeficiency virus was 15.9%. This study assessed determinants of human immunodeficiency virus infection among infants born to human immunodeficiency virus positive women on option B + prevention of mother to child transmission of human immunodeficiency virus in Tigray, north Ethiopia. Methods: Unmatched case-control study was conducted in Tigray region from October 2023 to April 2024. A total of 43 cases and 129 controls were selected using simple random sampling technique. Multivariable logistic regression analysis was fitted to identify the factors associated with mother to child transmission of human immunodeficiency virus at P < 0.05. Multicolinearity was checked among predictor variables using Variance Inflation Factor and Tolerance test. Furthermore, the goodness of fit of the logistic model was tested using Hosmer-Lemshow test. Results: This study showed that rural residence (Adjusted Odds ratio: 33.3, 95% CI: 1.02–87.05), World Health Organization disease stage III (Adjusted Odds ratio: 57.4, CI: 9.25– 297.54) and IV (Adjusted Odds ratio: 78.9, CI: 12.64–345.62) during initiation of antiretroviral therapy and a child with mouth ulcer during exclusive breastfeeding (Adjusted Odds ratio: 65, IC: 6.39–456.23) were the factors significantly associated with mother to child transmission of human immunodeficiency virus. Besides, mothers’ educational status (Adjusted Odds ratio: 0.2, CI: 0.04, 0.35), late time of antiretroviral therapy initiation after human immunodeficiency virus diagnosis (Adjusted Odds ratio: 0.14, CI: 0.02–0.18) and absence of human immunodeficiency virus exposed infant follow up visit (Adjusted Odds ratio: 0.04, IC: 0.005–0.09) had significant association with the mother to child transmission of human immunodeficiency virus. Conclusion: The determinant factors significantly associated with mother to child transmission of human immunodeficiency virus were identified. Health care providers should strengthen option B + prevention mother to child transmission of human immunodeficiency virus services to reduce the mother to child transmission of human immunodeficiency virus.


  • Open Access

    WHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study

    by Gebretekle Gebremichael Hailesilase, Brhane Gebrehiwot Welegebrial, Mezgebe Gidey Weres, Senait Abera Gebrewahd

    The World Health Organization (WHO) defines rational use of drug as a state in which medications are received by patients appropriately according to their clinical needs and individual requirement, for adequate period and at the right cost. More than 50% of all medicines are prescribed, dispensed, or sold inappropriately worldwide. This study aimed to evaluate the prescribing patterns in Adigrat general hospital, Tigrai, Ethiopia. A retrospective cross-sectional study was done to evaluate prescription patterns. A systematic random sampling technique was used to select 600 prescriptions and the prescriptions were reviewed using WHO/International Network of Rational Use of Drugs prescribing indicators. Data was collected from prescriptions dispensed from 01 March 2023 to 30 March 2024 at outpatient pharmacy of Adigrat general hospital. Data was analyzed using SPSS version 21 and a p-value < 0.05 was declared statistically significant. A total of 1088 medicines were prescribed in 600 prescription encounters, giving an average number of 1.8 (± 0.83) medicines per encounter. The percentage of medicines prescribed by generic name was 91.5% while 98.7% of the medicines were prescribed from essential medicine list (EML). Besides, the percentages of encounters containing at least one antibiotic and one injection were 44.5% and 7.2%, respectively. A total of 340 antibiotics were prescribed in 267 encounters. Penicillins (34.4%), macrolides (23.8%) and fluoroquinolones (17.1%) were the most prevalent antibiotics classes. The “Access” and “Watch” groups covered 54.4% and 45.6% of the total antibiotics prescribed, respectively. Being under 18 years old [Adjusted Odds Ratio (AOR): 9.830, CI: 4.062–23.786], being prescribed with three medicines (AOR: 3.247, CI: 1.571–6.708) and certain diagnosis like diseases of the respiratory system (AOR: 3.750, CI: 2.136–6.584) were significantly associated with antibiotic prescribing. This study showed deviations of prescribing patterns from WHO standards. The percentage of prescriptions with antibiotic was far from WHO optimal value. The use of antibiotics from “Access” group was below WHO standard. The percentage of medicines prescribed by generic name and the percentage of encounters with injection also deviated from WHO standard. Antibiotics prescribing showed significantly association with age, number of medicines and certain diseases.


  • Open Access

    Potential drug-drug interactions and associated factors among hospitalized pediatric patients in Adigrat general hospital, Tigrai, north Ethiopia: a retrospective cross-sectional study

    by Gebretekle Gebremichael Hailesilase, Abrahaley Mulu Kidane, Haylay Araya Gebrezgabiher

    Drug-drug interactions (DDIs) are associated with increased or decreased adverse effects and decreased or decreased therapeutic effects. Hospitalized pediatric patients are exposed to a number of potential DDIs (pDDIs). There are limited studies on pDDIs among pediatric patients in Ethiopia. This study was aimed to evaluate the pDDIs and associated factors among hospitalized pediatric patients in Adigrat general hospital, Tigrai, northern Ethiopia. A retrospective cross-sectional study was carried out among hospitalized pediatric patients in Adigrat general hospital from 01 July 2020 to 31 August 2020. A simple random sampling technique was used to select medical charts. Micromedex 2.0 database was used to screen pDDIs. Data was analyzed using statistical package for social science version 21 and a P-value of ≤ 0.05 was considered statistically significant. Of the total 146 patients studied, 100 (68.5%) were exposed for at least one pDDI. A total of 158 pDDIs consisting of 33 distinct interacting drug pairs were identified. About 19.3% of the patients had at least one major pDDI, 6.7% at least one moderate and 68.9% at least one minor pDDIs. On the other hand, 63.3% of the total pDDIs were minor and 25.9% major while 3. 8% were contraindicated pDDIs with 15.2% fair and 81.6% good level of documentation. The overall mean duration of pDDIs exposure was about 4.9 (1-23) days. The frequently occurring potential clinical consequences of pDDIs comprised increased risk of QT-interval prolongation (10.1%), theophylline toxicity (5.1%), antiepileptic toxicity (5.1%) and formation of ceftriaxone calcium precipitates (3.8%). Infant/toddler age group (adjusted odds ratio [AOR] = 31.961, 95% CI: 1.117-914.528), number of diseases (AOR = 0.255, 95% CI: 0.069-0.939) and polypharmacy (AOR = 0.276, 95% CI: 0.091-0.838) were associated with pDDIs exposures. A large number of pediatric patients were exposed to a various pDDIs. Age, number of diseases and polypharmacy predicted for the occurrence of pDDIs. Besides, the major severity pDDIs encounted frequently in the current study can potentially lead to a life threatening cardio-vascular toxicicty from QT-interval prolongation. Clinicians should be vigilant to pDDIs to prevent potential clinical consequences of pDDIs. Moreover, computerized drug interaction screening and clincal pharmacy services should be practiced to improve patients’ safety.


  • Open Access

    In Vivo Antimalarial Evaluation of Crude Extract, Solvent Fractions, and TLC‐Isolated Compounds from Olea europaea Linn subsp. cuspidata (Oleaceae)

    by Gebretekle Gebremichael Hailesilase, Yarra Rajeshwar, Gebremedhin Solomon Hailu, Gereziher Gebremedhin Sibhat, Helen Bitew

    Malaria is a major global public health problem caused by Plasmodium parasites. Drug resistance is becoming a great challenge. New drugs with novel mechanism of action are urgently required. In malarious countries, medicinal plants are commonly used for malaria treatment. Olea europaea is traditionally used against malaria in Ethiopia. The aim of this study was to isolate and evaluate antimalarial activity of chemical constituents extracted from Olea europaea against chloroquine‐sensitive Plasmodium berghei‐infected mice. Stem bark of Olea europaea was extracted with 80% methanol and fractionated with three solvents. The butanol fraction was subjected to isolation with preparative thin‐layer chromatography (PTLC). Acute oral toxicity studies were conducted in mice as per the Organization for Economic Co‐operation and Development (OECD) guideline 425. Antimalarial activities of the test substances were evaluated using Peter’s 4‐day suppressive test. The crude extract showed significant (p < 0.01) antiplasmodial activity at all doses with a chemosuppression value of 52.40% at a dose of 600 mg/kg. All fractions also suppressed parasitaemia significantly (p < 0.05), the highest suppression (45.42%) being with butanol fraction. In the phytochemical analysis, two compounds were isolated. Both compounds showed significant (p < 0.05) antimalarial activities. Compound C inhibited parasitaemia up to 38.19% at a dose of 200 mg/kg. The crude extract, butanol fraction, and isolated compounds also prolonged survival time of mice. No sign of toxicity and mortality was seen in the test substances at up to a single dose of 2 g/kg. Findings of the current study may confirm the traditional antimalarial claim of Olea europaea and its relative safety as well as the potentiality of compound C for further investigations.